These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29200520)

  • 21. 25 years of the WHO essential medicines lists: progress and challenges.
    Laing R; Waning B; Gray A; Ford N; 't Hoen E
    Lancet; 2003 May; 361(9370):1723-9. PubMed ID: 12767751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. China issues the National Essential Medicines List (2018 edition): Background, differences from previous editions, and potential issues.
    He J; Tang M; Ye Z; Jiang X; Chen D; Song P; Jin C
    Biosci Trends; 2018; 12(5):445-449. PubMed ID: 30473550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No deal in sight on cheap drugs for poor countries.
    Fleck F
    Bull World Health Organ; 2003; 81(4):307-8. PubMed ID: 12764500
    [No Abstract]   [Full Text] [Related]  

  • 24. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medicine supplies in developing countries: saving public medicine procurement bodies in Africa].
    Barbereau S
    Med Sante Trop; 2013; 23(3):251-5. PubMed ID: 24126191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global aspects of drug development.
    Hoppu K; Hogerzeil HV
    Handb Exp Pharmacol; 2011; 205():353-72. PubMed ID: 21882121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adherence to essential medicines in cities from three Brazilian states].
    Dal Pizzol Tda S; Trevisol DJ; Heineck I; Flores LM; Camargo AL; Köenig A; Torres IL; Kadri MC; Monreal MT; Melo AM; Ferreira MB
    Cad Saude Publica; 2010 Apr; 26(4):827-36. PubMed ID: 20512222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the pharmaceutical industry improving with regard to access to essential medicines?
    Hogerzeil HV; Iyer JK; Urlings L; Prasad T; Brewer S
    Lancet Glob Health; 2014 Mar; 2(3):e139-40. PubMed ID: 25102843
    [No Abstract]   [Full Text] [Related]  

  • 29. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medicines prices and Malaysia--untangling the medicines web.
    Hill S
    PLoS Med; 2007 Mar; 4(3):e149. PubMed ID: 17388686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic drug use in Bangladesh: policy versus practice.
    Islam MS
    Indian J Med Ethics; 2008; 5(1):24-5. PubMed ID: 18630250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Threat of compulsory licences could increase access to essential medicines.
    Ooms G; Hanefeld J
    BMJ; 2019 May; 365():l2098. PubMed ID: 31138530
    [No Abstract]   [Full Text] [Related]  

  • 33. The Revolving Fund Pharmacy Model: backing up the Ministry of Health supply chain in western Kenya.
    Manji I; Manyara SM; Jakait B; Ogallo W; Hagedorn IC; Lukas S; Kosgei EJ; Pastakia SD
    Int J Pharm Pract; 2016 Oct; 24(5):358-66. PubMed ID: 26913925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shortages of inexpensive essential medicines.
    Vyas M; de Vries EGE; Casali PG; Tabernero J
    Lancet Oncol; 2019 May; 20(5):e224-e225. PubMed ID: 31006527
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chapter 3. The moral economy of the availability of therapeutic innovations for neglected diseases].
    Trouiller P
    J Int Bioethique Ethique Sci; 2018 Jul; 29(2):53-67. PubMed ID: 30767447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs and vaccines around the world.
    Health Aff (Millwood); 2006; 25(2):312. PubMed ID: 16522572
    [No Abstract]   [Full Text] [Related]  

  • 37. Deadlock on access to cheap drugs at global trade negotiations.
    Hagmann M
    Bull World Health Organ; 2003; 81(2):150-1. PubMed ID: 12751424
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
    Cameron A; Ewen M; Ross-Degnan D; Ball D; Laing R
    Lancet; 2009 Jan; 373(9659):240-9. PubMed ID: 19042012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essential medicines for hepatitis C: at what price?
    Balakrishnan VS
    Lancet Infect Dis; 2017 Sep; 17(9):904-905. PubMed ID: 28845797
    [No Abstract]   [Full Text] [Related]  

  • 40. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.